Editorial: Choosing New Targets for Rheumatoid Arthritis Therapeutics: Too Interesting to Fail?

Arthritis Rheumatol. 2017 Jun;69(6):1131-1134. doi: 10.1002/art.40082. Epub 2017 May 10.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Arthritis, Rheumatoid*
  • Double-Blind Method
  • Humans

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • secukinumab